Osteoarthritis (OA) is the most common form of arthritis. Some people call it degenerative joint disease or “wear and tear” arthritis. It occurs most frequently in the hands, hips, and knees.

With OA, the cartilage within a joint begins to break down and the underlying bone begins to change. These changes usually develop slowly and get worse over time. OA can cause pain, stiffness, and swelling. In some cases it also causes reduced function and disability; some people are no longer able to do daily tasks or work.

SAFE Pharmaceutical has done many successful cases on this disease model and has helped our client on NMPA IND application. Dr. Tian here introduces OA model in SAFE and our successful cases.

FEATURED SPEAKER:

Dr. Jun Tian 

Sub-Manager of Pharmacology and Pharmacodynamics Center 

SAFE Pharmaceutical Techonology Co., Ltd.

Dr. Tian got his Ph. D degree in Immunology and M.S. in Biochemistry. He is an Associate Professor of Immunology at the Institute of Cardiopulmonary and Vascular Research in Beijing. 

He has been working as a researcher at the Institute of Basic Medical Sciences, and worked as a laboratory manager in the U.S. for several years. Dr. Jun Tian is familiar with cutting-edge research in immunology, oncology immune drugs and therapeutics, and the evaluation of the pharmacology and pharmacological efficacy of animal and humanized models.

Next webinar will be coming soon....